All participants must register to attend the M-CERSI Conference on Patient-Focused Drug Development, a one-day conference scheduled for Monday, March 9, 2015.
Thank you for your interest in the M-CERSI Conference on Patient-Focused Drug Development, a conference by the University of Maryland, with planning members from the University of Maryland Center Excellence in Regulatory Science and Innovation (M-CERSI), Food and Drug Administration, academia, and industry. There is no cost to register for this event.
Conference Objectives:
This conference will provide a forum for all patient-focused drug development (PFDD) stakeholders to gather for an open dialogue. Patients, caregiver and patient advocacy groups; regulators from the Food and Drug Administration (FDA); researchers from academia, industry, payers, and other agencies; and other stakeholders will come together to discuss the:
- Definition of PFDD
- Essential components that need to be included in successful PFDD
- Current initiatives, such as those of the FDA, patient advocacy groups, and pharmaceutical companies
- Challenges to achieving PFDD and methods to overcome those challenges
- Recommendations on a plan of action that includes a description of stakeholders’ roles to move PFDD forward
How to Register:
Registration for this event is now closed.